Access cutting-edge copd treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access copd specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related copd treatment provided free
The purpose of this study is to evaluate the efficacy and the safety of two doses of CHF6001 (Tanimilast) as add-on to maintenance triple therapy in the target patient population.
Sponsor: Chiesi Farmaceutici S.p.A.
Check if you qualify for this copd clinical trial in Phoenix, AZ
If you're searching for copd treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced copd specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.